Related Experiment Videos
Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis
Liqun Ma1, Jian Zhong, Zhigang Zhao
1Department of Hypertension and Endocrinology, Center for Hypertension and Metabolic Diseases, Daping Hospital, Third Military Medical University, Chongqing Institute of Hypertension, Chongqing 400042, People' s Republic of China.
Aims:
Activation of transient receptor potential vanilloid type-1 (TRPV1) channels may affect lipid storage and the cellular inflammatory response. Now, we tested the hypothesis that activation of TRPV1 channels attenuates atherosclerosis in apolipoprotein E knockout mice (ApoE(-/-)) but not ApoE(-/-)TRPV1(-/-) double knockout mice on a high-fat diet.
Methods And Results:
Both TRPV1 mRNA and protein expression were identified in vascular smooth muscle cells (VSMC) and in aorta from C57BL/6J mice using RT-PCR, immunoblotting, and immunohistochemistry. In vitro, activation of TRPV1 by the specific agonists capsaicin and resiniferatoxin dose-dependently increased cytosolic calcium and significantly reduced the accumulation of lipids in VSMC from C57BL/6J mice but not from TRPV1(-/-) mice. TRPV1 activation increased ATP-binding cassette transporter A1 (ABCA1) expression and reduced low-density lipoprotein-related protein 1 (LRP1) expression in VSMC by calcium-dependent and calcineurin- and protein kinase A-dependent mechanisms. These results showed increased cellular cholesterol efflux and reduced cholesterol uptake. In vivo, long-term activation of TRPV1 by capsaicin for 24 weeks increased ABCA1 and reduced LRP1 expression in aorta from ApoE(-/-) mice on a high-fat diet. Long-term activation of TRPV1 significantly reduced lipid storage and atherosclerotic lesions in the aortic sinus and in the thoracoabdominal aorta from ApoE(-/-) mice but not from ApoE(-/-)TRPV1(-/-) mice on a high-fat diet. These findings indicated that TRPV1 activation ameliorates high-fat diet-induced atherosclerosis.
Conclusion:
Activation of TRPV1 may be a novel therapeutic tool to attenuate atherosclerosis caused by a high-fat diet.
Insights
Activation of transient receptor potential vanilloid type-1 (TRPV1) channels reduces atherosclerosis in mice on a high-fat diet. This suggests TRPV1 activation may be a novel therapeutic strategy for diet-induced atherosclerosis.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Background:
- Transient receptor potential vanilloid type-1 (TRPV1) channels are implicated in lipid metabolism and inflammation.
- Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries.
Purpose of the Study:
- To investigate the role of TRPV1 channel activation in attenuating atherosclerosis.
- To test if TRPV1 activation reduces atherosclerosis in apolipoprotein E knockout (ApoE(-/-)) mice on a high-fat diet.
Main Methods:
- Assessed TRPV1 expression in mouse vascular smooth muscle cells (VSMC) and aorta.
- Utilized in vitro and in vivo models, including ApoE(-/-) and ApoE(-/-)TRPV1(-/-) mice on a high-fat diet.
- Administered TRPV1 agonists (capsaicin, resiniferatoxin) to evaluate effects on lipid accumulation, gene expression (ABCA1, LRP1), and atherosclerotic lesions.
Main Results:
- TRPV1 activation in VSMC increased intracellular calcium, reduced lipid accumulation, upregulated ABCA1, and downregulated LRP1 expression.
- In ApoE(-/-) mice, long-term TRPV1 activation significantly reduced atherosclerotic lesions and lipid storage in the aorta.
- These beneficial effects were absent in ApoE(-/-)TRPV1(-/-) mice, confirming TRPV1 dependency.
Conclusions:
- TRPV1 activation ameliorates high-fat diet-induced atherosclerosis in mice.
- Targeting TRPV1 channels represents a potential novel therapeutic approach for atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Antihypertensive Drugs: Action of Calcium Channel Blockers
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation
Antihypertensive Drugs: Vasodilators